Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$745,049 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
13 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$1,222,416
CallShares
7,800
PutValue
$814,944
PutShares
5,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $847,064,370 across 13 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
151,950 | $182,253,403 | |
| 2 | ABBV |
AbbVie Inc.
|
622,946 | $156,758,131 | |
| 3 | JNJ |
Johnson & Johnson
|
584,500 | $148,445,465 | |
| 4 | SNY |
Sanofi
|
2,405,640 | $102,624,602 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
587,082 | $74,171,939 | |
| 6 | BIIB |
Biogen Inc.
|
265,090 | $57,275,345 | |
| 7 | NVO |
Novo Nordisk A S
|
1,109,982 | $53,212,537 | |
| 8 | OGN |
Organon & Co.
|
2,196,642 | $29,742,532 |
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,222,416 | 7,800 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $814,944 | 5,200 | Put | Sole | 2026-08-14 | |
| 2025-12-31 | $745,049 | 5,404 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $110,752,295 | 863,633 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $106,120,445 | 876,956 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $63,922,966 | 573,403 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,739,124 | 17,872 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $3,595,154 | 33,770 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,187,264 | 12,274 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $511,514 | 5,066 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $398,781 | 3,915 | Shares | Sole | 2023-11-14 | |
| 2021-12-31 | $11,291,327 | 129,088 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $28,612,667 | 303,004 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,696,000 | 100,000 | Put | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||